+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound loss of muscleblind-like function in myotonic dystrophy



Compound loss of muscleblind-like function in myotonic dystrophy



Embo Molecular Medicine 5(12): 1887-1900



Myotonic dystrophy (DM) is a multi-systemic disease that impacts cardiac and skeletal muscle as well as the central nervous system (CNS). DM is unusual because it is an RNA-mediated disorder due to the expression of toxic microsatellite expansion RNAs that alter the activities of RNA processing factors, including the muscleblind-like (MBNL) proteins. While these mutant RNAs inhibit MBNL1 splicing activity in heart and skeletal muscles, Mbnl1 knockout mice fail to recapitulate the full-range of DM symptoms in these tissues. Here, we generate mouse Mbnl compound knockouts to test the hypothesis that Mbnl2 functionally compensates for Mbnl1 loss. Although Mbnl1(-/-) ; Mbnl2(-/-) double knockouts (DKOs) are embryonic lethal, Mbnl1(-/-) ; Mbnl2(+/-) mice are viable but develop cardinal features of DM muscle disease including reduced lifespan, heart conduction block, severe myotonia and progressive skeletal muscle weakness. Mbnl2 protein levels are elevated in Mbnl1(-/-) knockouts where Mbnl2 targets Mbnl1-regulated exons. These findings support the hypothesis that compound loss of MBNL function is a critical event in DM pathogenesis and provide novel mouse models to investigate additional pathways disrupted in this RNA-mediated disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052269172

Download citation: RISBibTeXText

PMID: 24293317

DOI: 10.1002/emmm.201303275


Related references

Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy. Journal of the American Heart Association 6(4), 2017

Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy. Neurobiology of Disease, 2018

A muscleblind knockout model for myotonic dystrophy. Science 302(5652): 1978-1980, 2003

Muscleblind is associated with splicing alterations in myotonic dystrophy. American Journal of Human Genetics 73(5): 576, November, 2003

Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy. Developmental Dynamics 237(2): 403-410, 2008

Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy. Disease Models & Mechanisms 4(3): 381-392, 2011

Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. Embo Journal 19(17): 4439-4448, 2000

RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2. Neuron 95(6): 1292-1305.E5, 2017

Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. American Journal of Pathology 174(1): 216-227, 2009

Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Human Molecular Genetics 10(19): 2165-2170, 2001

Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. Plos One 7(3): E33218-E33218, 2012

Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. Journal of Cell Science 118(Pt 13): 2923-2933, 2005

Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75(3): 437-450, 2012

Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model. Disease Models & Mechanisms 6(1): 184-196, 2013

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proceedings of the National Academy of Sciences of the United States of America 103(31): 11748-11753, 2006